CONCLUSIONS: Zonisamide is safe, effectie and well tolerated at 25 to 100 mg/day as an adjunctie treatment in patients with Parkinson disease.
CONCLUSIONS: Zonisamide is safe, effectie and well tolerated at 25 to 100 mg/day as an adjunctie treatment in patients with Parkinson disease.
结论：唑尼沙胺作为帕金森疾病患者的辅助治疗，其每日剂量为25至100毫克是安全有效且耐受性良好的。